Osteosarcoma: all 446 studies
Page 1 of 5. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective StudyRecruitingNCT07878364
- Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to RelapseRecruitingNCT07871864Phase 3
- Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.Not yet recruitingNCT07853105Phase 1/2
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialNot yet recruitingNCT07820033Phase 2
- A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaNot yet recruitingNCT07801222Phase 1/2
- Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk OsteosarcomaRecruitingNCT07787429Phase 2
- 68Ga-B7-H3 Nanobody ImmunoPET in OsteosarcomaRecruitingNCT07774533Early Phase 1
- Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and OsteosarcomaRecruitingNCT07725380Phase 1/2
- Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced SarcomaRecruitingNCT07648069Phase 1
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaRecruitingNCT07602049Phase 2
- The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed OsteosarcomaRecruitingNCT07560826Phase 2
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young AdultsNot yet recruitingNCT07516353Not applicable
- Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's LymphomaRecruitingNCT07514819Not applicable
- Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer PatientsRecruitingNCT07502885
- Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaRecruitingNCT07479732Phase 1/2
- A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaRecruitingNCT07477457Phase 2
- Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid TumorsNot yet recruitingNCT07444918Phase 2
- Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk OsteosarcomaRecruitingNCT07428993Phase 2
- Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)RecruitingNCT07357519Phase 1/2
- Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaRecruitingNCT07321912Phase 2
- Implant-Related Infections in Patients With Skeletal SarcomasEnrolling by invitationNCT07264296
- Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe TrialRecruitingNCT07227571Phase 1
- NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or NeuroblastomaRecruitingNCT07211737Phase 1
- Tegavivint With Gemcitabine in Patients With Relapsed or Refractory OsteosarcomaRecruitingNCT07144254Phase 1
- Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma PatientsNot yet recruitingNCT07142863Phase 2
- Musculoskeletal Cancers Remote Monitoring and CareRecruitingNCT07129226Not applicable
- Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasRecruitingNCT07066982Phase 1/2
- Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone TumorsRecruitingNCT06935864
- A Look Back at How Well Interventional Treatments Work for Bronchopleural Fistulas in Patients With Lung Metastases From OsteosarcomaNot yet recruitingNCT06927596
- B7-H3 NIR Imaging for Osteosarcoma SurgeryRecruitingNCT06778603Phase 1/2
- Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical StudyNot yet recruitingNCT06776198
- Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed TomograhyNot yet recruitingNCT06726512Not applicable
- Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of OsteosarcomaRecruitingNCT06714383Phase 2
- Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory SarcomasRecruitingNCT06709495Phase 1/2
- ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.Not yet recruitingNCT06699576Phase 1
- A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade OsteosarcomaRecruitingNCT06650514Phase 2
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsRecruitingNCT06625190Phase 1/2
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
- XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue SarcomaRecruitingNCT06571734Phase 2
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsRecruitingNCT06541262Phase 1/2
- Single High-dose Brachytherapy for Giant Osteosarcoma MassesNot yet recruitingNCT06524778Phase 2
- Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid TumorsRecruitingNCT06500819Phase 1
- Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed OsteosarcomaRecruitingNCT06492954Phase 1
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasRecruitingNCT06465199Phase 1/2
- IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory OsteosarcomaNot yet recruitingNCT06412458Phase 1
- A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative PlanningRecruitingNCT06387485Not applicable
- Upfront Surgical Resection for OsteosarcomaRecruitingNCT06384404
- Donor Site Morbidity After Free Vascularized Fibular GraftRecruitingNCT06324916
- NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)RecruitingNCT06239272Phase 1/2
- Safety and Feasibility of Intraoperative Visualization With Cytalux in ChildrenRecruitingNCT06235125Phase 1
- Evaluation of Prophylactic Photobiomodulation Therapy in Patients With OsteosarcomaRecruitingNCT06217224Not applicable
- Trilaciclib Combined With Chemotherapy for Perioperative Treatment of OsteosarcomaNot yet recruitingNCT06217003Phase 2
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue TumorsRecruitingNCT06171282Early Phase 1
- Cabozantinib With Ifosfamide in Relapsed/Refractory SarcomasRecruitingNCT06156410Phase 1
- Tucidinostat Plus Apatinib for Advanced OsteosarcomaNot yet recruitingNCT06125171Phase 2
- Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue SarcomaRecruitingNCT06117878Early Phase 1
- Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialRecruitingNCT06114225Phase 2
- Insights Into Participating in Studies for Bone CancerNot yet recruitingNCT06070259
- An Organoid-based Functional Precision Medicine Trial in OsteosarcomaRecruitingNCT06064682
- Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver TransplantationNot yet recruitingNCT06041490Phase 2
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyRecruitingNCT06029218Not applicable
- An Observational Study of Local Relapse After High Grade OsteosarcomaRecruitingNCT06017518
- Soluble B7-H3 as a Biomarker for OsteosarcomaRecruitingNCT05942456
- A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in OsteosarcomaRecruitingNCT05926492Phase 2
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue TumorsRecruitingNCT05851456Early Phase 1
- ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other SarcomasRecruitingNCT05830123Phase 2
- Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage SurgeryRecruitingNCT05779670
- SPEARHEAD-3 Pediatric StudyRecruitingNCT05642455Phase 1/2
- A Study of Sulfatinib on Relapsed or Refractory Drug Resistant OsteosarcomaNot yet recruitingNCT05590572Phase 1/2
- Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaRecruitingNCT05588648Phase 1/2
- Assessing Clinical Trial Experiences of Patients With OsteosarcomaNot yet recruitingNCT05535283
- Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone SarcomasNot yet recruitingNCT05515068
- START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerRecruitingNCT05492682Phase 1
- Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed OsteosarcomaRecruitingNCT05400603Phase 1
- Use of GnRHa During Chemotherapy for Fertility ProtectionRecruitingNCT05328258Phase 3
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaRecruitingNCT05235165Phase 3
- AOH1996 for the Treatment of Refractory Solid TumorsRecruitingNCT05227326Phase 1
- Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory SarcomasRecruitingNCT05210374Phase 1
- Combination of Pembrolizumab and Cabozantinib in Patients With Advanced SarcomasRecruitingNCT05182164Phase 2
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsRecruitingNCT05135975Phase 2
- Early Ageing During Therapy in AYA Cancer PatientsRecruitingNCT05062707
- Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone TumorsRecruitingNCT05057130Phase 2/3
- Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyRecruitingNCT05019703Phase 2
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced SarcomaRecruitingNCT04995003Phase 1
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaRecruitingNCT04901702Phase 1/2
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
- Observational Study in Localized OsteosarcomaRecruitingNCT04890067
- Neutrophils in Bone SarcomasRecruitingNCT04867421
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of RelapseRecruitingNCT04758000Phase 2
- Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone SarcomaRecruitingNCT04735289
- Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas PatientsRecruitingNCT04698785Phase 2
- Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorRecruitingNCT04616560Phase 2
- Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and OsteosarcomaRecruitingNCT04595994Phase 1
- Expanded Access Use of L-MTP-PE for the Treatment of OsteosarcomaAvailableNCT04571229
- Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of OsteosarcomaNot yet recruitingNCT04319874Phase 2
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesRecruitingNCT04282044Phase 1